MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 103 filers reported holding MAXCYTE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $9,840,125 | -17.4% | 1,987,904 | -8.9% | 0.03% | -25.0% |
Q4 2022 | $11,919,082 | -19.1% | 2,182,982 | -3.7% | 0.04% | -16.7% |
Q3 2022 | $14,742,000 | +30.3% | 2,267,949 | -5.2% | 0.05% | +33.3% |
Q2 2022 | $11,310,000 | -64.8% | 2,391,158 | -48.0% | 0.04% | -54.4% |
Q1 2022 | $32,145,000 | -37.7% | 4,598,669 | -9.2% | 0.08% | -27.5% |
Q4 2021 | $51,614,000 | +173.8% | 5,065,171 | +228.1% | 0.11% | +153.5% |
Q3 2021 | $18,848,000 | – | 1,543,634 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 1,885,000 | $5,881,200 | 5.55% |
Vitruvian Partners LLP | 5,043,356 | $15,735,271 | 4.46% |
Stonepine Capital Management, LLC | 3,761,640 | $11,736,317 | 3.90% |
Mudita Advisors LLP | 1,390,858 | $4,339,477 | 3.17% |
RIVER GLOBAL INVESTORS LLP | 1,473,254 | $4,588,359 | 1.07% |
Casdin Capital, LLC | 1,890,000 | $5,896,800 | 0.65% |
Portolan Capital Management | 2,143,666 | $6,688,238 | 0.62% |
Grandeur Peak Global Advisors, LLC | 1,434,819 | $4,476,635 | 0.34% |
First Light Asset Management, LLC | 1,073,110 | $3,348,103 | 0.32% |
Granahan Investment Management | 1,975,847 | $6,164,643 | 0.22% |